Eliquis (apixaban) Letter of Medical Necessity
Eliquis (apixaban) is one of the most prescribed DOACs but faces significant prior authorization friction on Medicare Part D plans. A targeted LMN can overturn most denials.
FDA-Approved Indications
- ● stroke prevention in non-valvular atrial fibrillation
- ● treatment of DVT/PE
- ● extended treatment to reduce VTE recurrence
- ● VTE prophylaxis post hip/knee replacement
Why Eliquis Prior Authorization Gets Denied
The most common denial reasons across major payers:
- 1. Warfarin trial not documented
- 2. Indication not specified
- 3. CHA2DS2-VASc not on file
- 4. Step therapy through preferred DOAC
What to Include in a Eliquis Letter of Medical Necessity
Document indication, CHA2DS2-VASc score for AFib, prior anticoagulant history, contraindications to warfarin (labile INR, dietary issues, drug interactions), bleeding risk assessment, and renal function.
Key clinical evidence to cite:
- ✓ ARISTOTLE for AFib
- ✓ AMPLIFY and AMPLIFY-EXT for VTE
- ✓ ADVANCE-2/3 for VTE prophylaxis
Relevant guidelines:
- 📖 AHA/ACC/HRS 2023 AFib Guidelines
- 📖 CHEST 2021 Antithrombotic Guidelines
- 📖 ASH 2018 VTE Guidelines
Eliquis Prior Authorization Criteria
Standard criteria across major US payers for Eliquis. Specific criteria vary by plan — RxCheckUp tailors each LMN to your patient's exact payer policy.
Typical step therapy requirements:
- → Warfarin trial not documented
- → Step therapy through preferred DOAC
Required documentation:
- ✓ ICD-10 diagnosis code with specificity
- ✓ Prior therapy history with dates, doses, and discontinuation reasons
- ✓ Specialist evaluation (where applicable)
- ✓ Baseline disease activity or biomarker results
- ✓ Clinical rationale citing FDA labeling or guidelines
Approval details:
Initial approval: typically 6 months. Renewal: 12 months with documented clinical response.
Payers Covering Eliquis
RxCheckUp tailors each LMN to the specific payer's medical policy and step therapy requirements:
Eliquis Prior Authorization FAQ
Why was my Eliquis prior authorization denied?
The most common denial reasons for Eliquis are: Warfarin trial not documented; Indication not specified; CHA2DS2-VASc not on file; Step therapy through preferred DOAC.
What should a Eliquis Letter of Medical Necessity include?
Document indication, CHA2DS2-VASc score for AFib, prior anticoagulant history, contraindications to warfarin (labile INR, dietary issues, drug interactions), bleeding risk assessment, and renal function.
Which payers cover Eliquis?
Eliquis is covered by major US payers including Medicare Part D, UnitedHealthcare, Aetna, Cigna, BCBS, though formulary tier and prior authorization criteria vary.